This Week in Cancer Cell

Premium

In Cancer Cell this week, a team of US researchers report on targeting non-classic oncogenes for the treatment of T-cell acute lymphoblastic leukemia. PI3K/Akt activation is common in T-ALL, the team says. In this study, they report that the absence of PTEN phosphatase tumor suppressor function can lead to the PI3K-gamma or PI3K-delta isoforms supporting leukemogenesis alone, even though suppression of both isoforms was required to suppress tumor formation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.